Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Insight & Intelligence™

Related to Adventrx to Acquire SynthRx in Staged Stock-Base Deal for Phase III Sickle Cell Crisis Therapy

  • Blood Flow as Diagnostic Marker
    Jamming, or vaso-occlusion, could be used to distinguish sickle cell disease patients with poor outcomes from those with good outcomes.
  • Page 1 of 1 (1 items) 1 

GEN Poll

More » Poll Results » Archive »

GEN’s Hall of Shame

Will you be voting for any of the candidates on GEN’s Hall of Shame list in the next election?

Suggest a Poll